Neuren Pharmaceuticals Limited Financial Overview
Neuren Pharmaceuticals Limited's market cap is currently $1.66B. The company's EPS TTM is $0.079406915; its P/E ratio is 16.76; Neuren Pharmaceuticals Limited is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
